Search Results - Ruetsch-Chelli, C

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    PO.6.126 Anti-rituximab antibodies demonstrate neutralising capacity, associate with lower circulating drug levels and early relapse in patients undergoing treatment for systemic lupus erythematosus

    PO.6.126 Anti-rituximab antibodies demonstrate neutralising capacity, associate with lower circulating drug levels and early relapse in patients undergoing treatment for systemic l... by Wincup, C, Dunn, N, Ruetsch-Chelli, C, Manouchehrinia, A, Kharlamova, N, Naja, M, Seitz-Polski, B, Isenberg, D, Fogdell-Hahn, A, Ciurtin, C, Jury, E

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus

    Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus by Wincup, Chris, Dunn, Nicky, Ruetsch-Chelli, Caroline, Manouchehrinia, Ali, Kharlamova, Nastya, Naja, Meena, Seitz-Polski, Barbara, Isenberg, David A, Fogdell-Hahn, Anna, Ciurtin, Coziana, Jury, Elizabeth C

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    ANTI-RITUXIMAB ANTIBODIES DEMONSTRATE NEUTRALISING CAPACITY, ASSOCIATE WITH LOWER CIRCULATING DRUG LEVELS AND EARLY RELAPSE IN PATIENTS UNDERGOING TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS

    ANTI-RITUXIMAB ANTIBODIES DEMONSTRATE NEUTRALISING CAPACITY, ASSOCIATE WITH LOWER CIRCULATING DRUG LEVELS AND EARLY RELAPSE IN PATIENTS UNDERGOING TREATMENT FOR SYSTEMIC LUPUS ERYT... by Wincup, C, Dunn, N, Ruetsch-Chelli, C, Manouchehrinia, A, Kharlamova, N, Naja, M, Seitz-Polski, B, Isenberg, D, Fogdell-Hahn, A, Ciurtin, C, Jury, E

    Get full text
    Conference Proceeding
    Save to List
    Saved in:

Search Tools: